LGT Fund Management Co Ltd. Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

LGT Fund Management Co Ltd. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,230 shares of the medical equipment provider’s stock after buying an additional 230 shares during the quarter. LGT Fund Management Co Ltd.’s holdings in Intuitive Surgical were worth $642,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at $31,000. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter valued at $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.1 %

Shares of NASDAQ ISRG opened at $566.98 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a 50 day simple moving average of $570.66 and a two-hundred day simple moving average of $530.08. The stock has a market cap of $201.95 billion, a price-to-earnings ratio of 88.45, a PEG ratio of 5.85 and a beta of 1.39.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 12,598 shares of company stock worth $7,223,467. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.